Live Breaking News & Updates on Christopher gibson

Stay informed with the latest breaking news from Christopher gibson on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Christopher gibson and stay connected to the pulse of your community

Cherry Creek Investment Advisors Inc. Acquires Shares of 17,853 Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Cherry Creek Investment Advisors Inc. bought a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 17,853 shares of the company’s stock, valued at approximately $176,000. Other large investors have also recently made changes to their positions in […]

China , Tina-marriott-larson , Christopher-gibson , Recursion-pharmaceuticals , Cherry-creek-investment-advisors-inc , Recursion-pharmaceuticals-inc , Advisor-group , Baldwin-brothers , Insider-transactions-at-recursion-pharmaceuticals , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-down , Quarter-for-recursion-pharmaceuticals

New Approach To Polymer Printing

New Approach To Polymer Printing
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Germany , Australia , Flinders-university , South-australia , Lisboa , Portugal , German , Australian , Jasonr-gascooke , Mona-lisa , Samuel-tonkin , Jason-gascooke

Micro-Lisa: Making a mark with novel nano-scale laser writing

Micro-Lisa: Making a mark with novel nano-scale laser writing
phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.

Flinders-university , South-australia , Australia , Lisboa , Portugal , Australian , Justin-chalker , Christopher-gibson , Abigail-mann , Samuel-tonkin , Jason-gascooke , Mona-lisa

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.9% After Insider Selling

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.9% After Insider Selling
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tina-marriott-larson , Christopher-gibson , Recursion-pharmaceuticals-price-performance , Mubadala-investment-co , Recursion-pharmaceuticals , Blackrock-inc , Recursion-pharmaceuticals-company-profile , Securities-exchange-commission , Hedge-funds-weigh-in-on-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Vanguard-group-inc , Needham-company

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $430,743.34 in Stock

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $430,743.34 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Christopher-gibson , Quarter-for-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Recursion-pharmaceuticals-inc , Recursion-pharmaceuticals , Nasdaq , Principal-financial-group-inc , Baldwin-brothers , Ameritas-investment-partners-inc , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-performance

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Christopher-gibson , Michael-secora , Recursion-pharmaceuticals-company-profile , Securities-exchange-commission , Recursion-pharmaceuticals , Nasdaq , Recursion-pharmaceuticals-stock-performance , Jpmorgan-chase-co , Needham-company , Sumitomo-mitsui-trust-holdings-inc , News-ratings-for-recursion-pharmaceuticals-daily , Nvidia-corp

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Christopher-gibson , Michael-secora , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals , Securities-exchange-commission , Needham-company , Nasdaq , Recursion-pharmaceuticals-stock-performance , Jpmorgan-chase-co , Nvidia-corp , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down to $15.52

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down to $15.52
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , China , Christopher-gibson , Needham-company , Insider-activity-at-recursion-pharmaceuticals , First-horizon-advisors-inc , Recursion-pharmaceuticals , China-universal-asset-management-co , Nasdaq , National-bank , Recursion-pharmaceuticals-trading , News-ratings-for-recursion-pharmaceuticals-daily

Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target Increased to $17.00 by Analysts at Needham & Company LLC

Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price upped by Needham & Company LLC from $15.00 to $17.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also recently issued reports on RXRX. TD Cowen initiated coverage on Recursion Pharmaceuticals […]

Christopher-gibson , Tina-marriott , Investment-management , Needham-company , Recursion-pharmaceuticals-inc , Vanguard-group-inc , Insider-transactions-at-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Recursion-pharmaceuticals-company-profile , Sumitomo-mitsui-trust-holdings-inc , Jpmorgan-chase-co , Blackrock-inc

Recursion Pharmaceuticals (NASDAQ:RXRX) Sees Unusually-High Trading Volume

Recursion Pharmaceuticals (NASDAQ:RXRX) Sees Unusually-High Trading Volume
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Christopher-gibson , Tina-marriott-larson , Needham-company , Principal-financial-group-inc , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-performance , Raymond-james-associates , Jpmorgan-chase-co , Investment-management , Barclays-plc , Nasdaq , Insider-transactions-at-recursion-pharmaceuticals